SETDB1 Amplification Emerges as a Promising Target for Innovative Osteosarcoma Therapies
SETDB1 amplification in osteosarcoma presents a striking development in oncology research, showcasing the intricate relationship between genetic anomalies and cancer progression. Recent findings suggest that...